Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
As a selective ghrelin receptor agonist, anamolin is approved in Japan for impro···【more】
Release date：2024-08-21Recommended：196
Through its unique pharmacological effects, Anamoreline is effective in helping ···【more】
Release date：2024-08-21Recommended：175
Anamorelin helps cancer patients with dyscrasia restore the body's energy su···【more】
Release date：2024-08-21Recommended：224
In 2021, Japan approved Anamorelin for the treatment of cachexia caused by vario···【more】
Release date：2024-08-21Recommended：259
Anamorelin is a novel ghrelin receptor agonist specifically designed for the tre···【more】
Release date：2024-08-21Recommended：329
Anamorelin is a selective oral medication that increases a patient's appetit···【more】
Release date：2024-08-21Recommended：241
Anamorelin is a ghrelin receptor agonist that is effective in improving appetite···【more】
Release date：2024-08-21Recommended：287
Anamorelin, the world's first oral drug specifically for the treatment of ca···【more】
Release date：2024-08-21Recommended：211
Koselugois a small molecule drug inhibitor targeting the MEK signaling pathway, ···【more】
Release date：2024-08-21Recommended：190
Koselugois a small molecule inhibitory drug targeting the MEK signaling pathway,···【more】
Release date：2024-08-21Recommended：208
Koselugo, as a small molecule blocker of the MEK signaling pathway, has a core e···【more】
Release date：2024-08-21Recommended：270
Koselugo is a small molecule inhibitor targeting the MEK signaling pathway, main···【more】
Release date：2024-08-21Recommended：240
